Elbit Medical Technologies Ltd (EMTC-M.TA)
ILA 16.1
(6.62%)
ILA 16.1
(6.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -590 Thousand | -526 Thousand | -547 Thousand | -674 Thousand | -571 Thousand | -190 Thousand |
| Net Income | -17.79 Million | -5.11 Million | -15.52 Million | 123.04 Million | -21.22 Million | 26.82 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 1000.00 | 6000.00 | 27 Thousand | 65 Thousand |
| Change in working capital | -19 Thousand | 84 Thousand | -44 Thousand | -75 Thousand | -136 Thousand | 663 Thousand |
| Other non-cash items | 17.22 Million | 4.5 Million | 15.01 Million | -123.65 Million | 20.75 Million | -27.73 Million |
| Investing Cash Flow | 2.02 Million | -1.95 Million | 41.56 Million | 72.33 Million | 2.16 Million | -3.64 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | 109.03 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 1.33 Million | 7.43 Million | - | - |
| Other Investing Activities | 2.02 Million | -1.95 Million | 40.23 Million | -44.12 Million | 2.16 Million | -3.64 Million |
| Financing Cash Flow | - | -411 Thousand | -42.93 Million | -66.83 Million | -2.54 Million | 5.75 Million |
| Debt repayment | - | - | -36 Million | -23.09 Million | - | -37.95 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -411 Thousand | -3.52 Million | -40.3 Million | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -3.4 Million | -3.43 Million | -2.54 Million | 43.7 Million |
| Accounts receivables | - | -2000.00 | 27 Thousand | 1000.00 | -24 Thousand | -5000.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -19 Thousand | 86 Thousand | -71 Thousand | -76 Thousand | -112 Thousand | - |
| Cash at beginning of period | -35 Thousand | 3.5 Million | 5.24 Million | -95 Thousand | 103 Thousand | 32 Thousand |
| Cash at end of period | 1.64 Million | 254 Thousand | 3.5 Million | 5.24 Million | 511 Thousand | 1.35 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 254 Thousand | -356 Thousand | 180 Thousand | 511 Thousand | 1.35 Million | -591 Thousand |
| Net cash flow / Change in cash | 1.68 Million | -3.25 Million | -1.73 Million | 5.33 Million | 408 Thousand | 1.32 Million |
| Free Cash Flow | -590 Thousand | -526 Thousand | -547 Thousand | -674 Thousand | -571 Thousand | -190 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 218 Thousand | 218 Thousand | -7.63 Million | -17.79 Million | -7.63 Million | -1.26 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -5000.00 | -5000.00 | 5500.00 | -19 Thousand | 5500.00 | -5500.00 |
| Other non-cash items | -361 Thousand | -361 Thousand | 7.48 Million | 17.22 Million | 7.48 Million | 1.11 Million |
| Investing Cash Flow | 70 Thousand | 70 Thousand | 11 Thousand | 2.02 Million | 11 Thousand | 999 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 70 Thousand | 70 Thousand | 11 Thousand | 2.02 Million | 11 Thousand | 999 Thousand |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -5000.00 | -5000.00 | 5500.00 | - | 5500.00 | -5500.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | - | -35 Thousand | - | - |
| Cash at end of period | -105.5 Thousand | -105.5 Thousand | -118.5 Thousand | 1.64 Million | -118.5 Thousand | 816 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -27.5 Thousand | -27.5 Thousand | 13.5 Thousand | 254 Thousand | 13.5 Thousand | -31 Thousand |
| Net cash flow / Change in cash | -105.5 Thousand | -105.5 Thousand | -118.5 Thousand | 1.68 Million | -118.5 Thousand | 816 Thousand |
| Free Cash Flow | -148 Thousand | -148 Thousand | -143 Thousand | -590 Thousand | -143 Thousand | -152 Thousand |
259960
443060
1775
004140
600693
2798